160 related articles for article (PubMed ID: 37695111)
1. Prevalence of Hepatobiliary Manifestations in Inflammatory Bowel Disease: A GRADE Assessed Systematic Review and Meta-Analysis of more than 1.7 Million Patients.
Beheshti Maal A; Shahrbaf MA; Sadri B; Hossein-Khannazer N; Mansournia MA; Vosough M
J Crohns Colitis; 2024 Mar; 18(3):360-374. PubMed ID: 37695111
[TBL] [Abstract][Full Text] [Related]
2. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
Rojas-Feria M; Castro M; Suárez E; Ampuero J; Romero-Gómez M
World J Gastroenterol; 2013 Nov; 19(42):7327-40. PubMed ID: 24259964
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients.
Silva J; Brito BS; Silva INN; Nóbrega VG; da Silva MCSM; Gomes HDN; Fortes FM; Pimentel AM; Mota J; Almeida N; Surlo VC; Lyra A; Rocha R; Santana GO
Biomed Res Int; 2019; 2019():7604939. PubMed ID: 30834274
[TBL] [Abstract][Full Text] [Related]
5. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.
Navaneethan U; Shen B
Inflamm Bowel Dis; 2010 Sep; 16(9):1598-619. PubMed ID: 20198712
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Kilic Y; Kamal S; Jaffar F; Sriranganathan D; Quraishi MN; Segal JP
Inflamm Bowel Dis; 2024 Feb; 30(2):230-239. PubMed ID: 37042969
[TBL] [Abstract][Full Text] [Related]
7. Hepatic manifestations of inflammatory bowel diseases.
Restellini S; Chazouillères O; Frossard JL
Liver Int; 2017 Apr; 37(4):475-489. PubMed ID: 27712010
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: A systematic review and meta-analysis.
Zhang Y; Gao X; He Z; Jia H; Chen M; Wang X; Hong L; Cui Y; Wan J
Liver Int; 2022 Aug; 42(8):1814-1822. PubMed ID: 35689520
[TBL] [Abstract][Full Text] [Related]
9. Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease.
Gizard E; Ford AC; Bronowicki JP; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2014 Jul; 40(1):3-15. PubMed ID: 24815622
[TBL] [Abstract][Full Text] [Related]
10. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks.
Massironi S; Pirola L; Mulinacci G; Ciaccio A; Viganò C; Palermo A; Zilli A; Invernizzi P; Danese S
Inflamm Bowel Dis; 2023 Sep; 29(9):1477-1487. PubMed ID: 36040402
[TBL] [Abstract][Full Text] [Related]
11. The Prevalence and Associated Risk Factors of Erectile Dysfunction in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Wu X; Zhang Y; Zhang W; Liu G; Huang H; Jiang H; Zhang X
J Sex Med; 2022 Jun; 19(6):950-960. PubMed ID: 35491378
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease.
Zamani M; Alizadeh-Tabari S; Singh S; Loomba R
Aliment Pharmacol Ther; 2022 Apr; 55(8):894-907. PubMed ID: 35274325
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Barberio B; Massimi D; Cazzagon N; Zingone F; Ford AC; Savarino EV
Gastroenterology; 2021 Dec; 161(6):1865-1877. PubMed ID: 34425093
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Lin A; Roth H; Anyane-Yeboa A; Rubin DT; Paul S
Inflamm Bowel Dis; 2021 May; 27(6):947-955. PubMed ID: 32780094
[TBL] [Abstract][Full Text] [Related]
15. Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.
Fousekis FS; Theopistos VI; Katsanos KH; Tsianos EV; Christodoulou DK
Gastroenterology Res; 2018 Apr; 11(2):83-94. PubMed ID: 29707074
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease : A Systematic Review and Meta-analysis.
Tariq R; Syed T; Yadav D; Prokop LJ; Singh S; Loftus EV; Pardi DS; Khanna S
J Clin Gastroenterol; 2023 Mar; 57(3):285-293. PubMed ID: 34864789
[TBL] [Abstract][Full Text] [Related]
17. Psychiatric Disorders in Adult and Paediatric Patients With Inflammatory Bowel Diseases - A Systematic Review and Meta-Analysis.
Arp L; Jansson S; Wewer V; Burisch J
J Crohns Colitis; 2022 Dec; 16(12):1933-1945. PubMed ID: 35775920
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical features of patients with autoimmune pancreatitis and inflammatory bowel disease: A systematic review and meta-analysis.
Fukuda S; Akiyama S; Tarakji A; Hamdeh S; Suzuki H; Tsuchiya K
J Gastroenterol Hepatol; 2022 Aug; 37(8):1474-1484. PubMed ID: 35596263
[TBL] [Abstract][Full Text] [Related]
19. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
Kujundzić M
Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Complications of Inflammatory Bowel Disease.
Mahfouz M; Martin P; Carrion AF
Clin Liver Dis; 2019 May; 23(2):191-208. PubMed ID: 30947871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]